BELX Bio-Pharmaceutical has been selected to participate in the U.S. Department of Commerce's 2021 SelectUSA Investment Summit as a Taiwan business representative and MedTech presenter.

The SelectUSA Investment Summit is the highest profile event organized by the U.S. Department of Commerce to promote foreign direct investment (FDI) in the United States. The Summit attracts a wide range of senior government officials, corporate executives and industry leaders to discuss the current U.S. investment environment, industry trends and the latest investment opportunities. Through the Summit, companies will have the opportunity to meet representatives from economic development agencies from around the U.S. and directly negotiate new business opportunities in the U.S. Being selected as presentative and MedTech presenter, It will be beneficial for our company to establish and to expand our business at U.S. in the futrure.